To: Savant who wrote (2 ) 7/12/2001 11:33:11 AM From: Savant Read Replies (1) | Respond to of 6 BMED..BEI Medical Signs Distribution Agreement for Southeast TETERBORO, N.J., Jun 22, 2001 (BUSINESS WIRE) -- BEI Medical Systems, Inc. (NASDAQ: BMED chart, msgs), which received U.S. Food and Drug Administration approval on April 20 to market its Hydro ThermAblator(R), or HTA(R), announced today that it has signed an exclusive distribution agreement for the Southeast U.S. with Adler Instrument Company, a well-established gynecological products distributor based in Norcross, Georgia. Adler is the first group of independent field representatives chosen by BEI Medical to market the HTA as the company establishes a nationwide distribution network. Under the agreement, 19 Adler sales representatives will introduce the HTA to a large market of gynecologists covering Florida, Georgia, South Carolina, North Carolina, Alabama, Tennessee and portions of Virginia. Each member of the sales-representative group specializes in the sale of gynecological products. The HTA is a proprietary, minimally invasive system for treating menorrhagia, or dysfunctional menstrual bleeding. Used to perform endometrial ablation, which destroys all or most of the endometrium, the lining of the uterus and the source of menstrual bleeding, the treatment can be performed by a gynecologist on an outpatient basis in approximately half an hour. "This is a very effective way to reach our target market and jump-start our sales program," said Richard Turner, CEO of BEI Medical. "Signing Adler Instrument Company as our first distributor is directly in sync with our overall sales strategy of engaging on an exclusive basis with selected distributors to quickly and effectively blanket the United States, region by region. We look forward to a vigorous and successful sales effort." "Our field sales force is eager to add BEI's HTA to our existing gynecological product line," said Robert E. Davis, Adler's president. "With our experience and well-established presence in the Southeast, we are confident that this agreement will produce a win-win for both companies." About BEI Medical Systems BEI Medical Systems Company, Inc., is a company focused on gynecology. The company has received approval from the FDA to market in the United States its sole product, the Hydro ThermAblator (HTA), a proprietary system that is intended to treat menorrhagia, or dysfunctional uterine bleeding. BEI Medical Systems(R), Hydro ThermAblator(R) and HTA(R) are registered trademarks of BEI Medical Systems Company, Inc., in the United States and certain foreign countries. For more information, please visit the company's web site at www.beimedical.com.